Doctor profile · Federal record
Dr. FILAMER KABIGTING, M.D.
Dermatology Physician (CMS: DERMATOLOGY) · Dermatopathology Physician · NEW YORK, NY
- NPI 1295050722
- Accepts Medicare
- MIPS 88.8 / 100 · 2023
- 16 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
161 FORT WASHINGTON AVE, 12TH FLOOR
NEW YORK, NY 100323729
(212) 305-5293 - Mailing address
-
PO BOX 29211
NEW YORK, NY 100872911
Credentials & registration
- NPI registered
- March 2010 — 16 yrs on file
- Profile last updated
- June 5, 2015
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #269594
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1295050722. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
13,354
Distinct HCPCS
10
Medicare allowed
$500,384
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 6,400 | 24 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,111 | 503 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,218 | 909 | $98 | |
17000 |
Destruction of precancer skin growth, 1 growth | 944 | 700 | $57 | |
11102 |
Biopsy of related skin growth, first growth | 623 | 520 | $101 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 520 | 404 | $139 | |
17110 |
Destruction of skin growth, 1-14 growths | 380 | 325 | $123 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 245 | 203 | $62 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 158 | 158 | $123 | |
11103 |
Biopsy of related skin growth, each additional growth | 153 | 125 | $56 |
In context: peer comparison
Among 139 peers in this city , average services per provider: 182. This provider delivers 73× the peer median.Open Payments
Industry payments received
All-time total
$2,953
Transactions
136
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 29 | $561.85 | |
| Regeneron Healthcare Solutions, Inc. | 11 | $439.92 | |
| E.R. Squibb & Sons, L.L.C. | 22 | $390.91 | |
| Janssen Biotech, Inc. | 7 | $269.62 | |
| Dermavant Sciences, Inc. | 19 | $228.37 | |
| GENZYME CORPORATION | 8 | $183.59 | |
| Lilly USA, LLC | 10 | $150.02 | |
| Incyte Corporation | 6 | $131.45 | |
| UCB, Inc. | 4 | $120.59 | |
| LEO Pharma Inc. | 4 | $94.13 | |
| Galderma Laboratories, L.P. | 5 | $89.17 | |
| Amgen Inc. | 3 | $73.12 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $50.63 | |
| Arcutis Biotherapeutics, Inc. | 3 | $47.83 | |
| Novartis Pharmaceuticals Corporation | 2 | $43.37 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,499
Patients
909
Total drug cost
$337,836
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 276 | 164 | $6,744 |
| Clobetasol Propionate | Generic | 264 | 177 | $15,756 |
| Triamcinolone Acetonide | Generic | 148 | 102 | $2,903 |
| Finasteride | Generic | 132 | 41 | $1,389 |
| Hydrocortisone | Generic | 94 | 67 | $755 |
| Fluocinonide | Generic | 85 | 57 | $4,615 |
| Dupixent Pen (Dupilumab) | Brand | 76 | 13 | $280,102 |
| Hydroxyzine Hcl | Generic | 73 | 33 | $1,268 |
| Fluorouracil | Generic | 71 | 69 | $6,685 |
| Mupirocin | Generic | 71 | 49 | $749 |